Trials / Completed
CompletedNCT00011297
Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal
Alcohol Research Center - Treatment and Implications
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 160 (planned)
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NIH
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate a safe and useful medication for outpatient detoxification that is as effective as benzodiazepines in the short-term, and more effective in the protracted withdrawal period. Gabapentin (Neurontin) will be compared to a standard benzodiazepine, lorazepam (Ativan), for its effectiveness in treating alcohol withdrawal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gabapentin (Neurontin) | |
| DRUG | lorazepam (Ativan) |
Timeline
- Completion
- 2005-12-01
- First posted
- 2001-02-19
- Last updated
- 2006-10-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00011297. Inclusion in this directory is not an endorsement.